Naltrexone Hydrochloride Implants (Shenzhen Sciencare Medical Industries )

盐酸纳曲酮植入剂 (深圳善康医药科技)

Report date: 2025/08/26 17:18:08

Base Information

Drug NameNaltrexone Hydrochloride Implants (Shenzhen Sciencare Medical Industries )
Drug Alias Name纳曲酮植入剂纳曲酮植入剂 (2.2类改良型)盐酸纳曲酮超长植入剂 (深圳善康医药科技)澳立康SK1801 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionOpioid receptors antagonists
TargetsOpioid receptors
Therapy Area/IndicationsOpium DependenceOpioid-Related Disorders
Global Approved IndicationsOpioid-Related Disorders
Approved Indications in ChinaOpioid-Related Disorders
Original Approved Country/TerritoryMainland China
Original Approved Date2024/06/25
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesShenzhen Sciencare Medical Industries Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Sciencare Medical Industries Co Ltd
Inactive CompaniesInstitute Of Traditional Chinese Medicine Hunan Academy Of Traditional Chinese MedicineHunan Saiwo Pharmaceutical Co Ltd
Active IndicationsOpioid-Related Disorders
Inactive IndicationsOpium Dependence

Other Information

ATC CodeN/A
Related LinksN/A